Full catalogue

Weight Loss Peptides in South Africa

This range is built around the incretin class: compounds that act on the receptors for GLP-1 and related gut hormones, which regulate appetite and blood sugar. Tirzepatide acts on two of them, GIP and GLP-1. Retatrutide adds a third, the glucagon receptor. Cagrilintide is an amylin analogue, a separate appetite pathway, studied both on its own and alongside semaglutide. These are the most heavily researched compounds on the site, with large human trials behind tirzepatide and published phase 2 data for retatrutide.

Alongside them sit compounds studied for fat metabolism by other routes. AOD-9604 is a fragment of growth hormone studied for fat breakdown. Tesamorelin is a GHRH analogue studied in clinical trials for visceral fat. 5-Amino-1MQ and SLU-PP-332 are earlier-stage compounds, studied in animal models for their effects on how cells use energy.

Two things are worth knowing in South Africa. Mounjaro, the registered tirzepatide medicine, is available on prescription, and most medical schemes do not fund GLP-1 drugs for weight loss; our articles on tirzepatide in South Africa and on medical aid cover explain both. And gastrointestinal effects in this class rise with dose, which is why the clinical trials increased doses slowly over weeks.

8 in stock · priced in rand · delivered across South Africa · research purposes only

Weight Loss & Metabolism: in stock

In Stock

5-Amino-1MQ

Inhibits NNMT enzyme activity to promote fat loss and improved cellular metabolism.

10mgR 450
In Stock

SLU-PP-332

An ERR agonist studied in mice as an “exercise mimetic” for endurance and fat oxidation. There is no human data yet.

5mgR 400
In Stock

AOD-9604

A modified hGH fragment designed to keep growth hormone’s fat-burning signal without its effects on growth or blood sugar.

5mgR 500
PopularIn Stock

Tesamorelin

A GHRH analogue studied in clinical trials for reducing visceral fat, by raising the body’s own growth hormone release.

Pre-combined Tesamorelin and Ipamorelin for optimised GH release with targeted visceral fat reduction.

10mg+5mgR 1 250
PopularIn Stock

Retatrutide

The most advanced weight loss peptide available: a triple agonist delivering superior fat reduction and metabolic control.

PopularIn Stock

Tirzepatide

Dual GIP/GLP-1 receptor agonist studied for weight loss and blood sugar control.

In Stock

Cagrilintide

A long-acting amylin analogue studied for appetite and weight, mostly with semaglutide as CagriSema.